In NAFLD, KLF6 regulates liver glucose and lipid metabolism by regulating the activity of PPARα and PPARα-regulated genes such as phosphoenolpyruvate carboxykinase (PEPCK) [61]. This evidence concerns the gene KLF6 and metabolic dysfunction-associated steatotic liver disease.